Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Bayer's mission is to provide new treatment options for diseases with high unmet medical need.
Bayer HealthCare allocates grants for the exploration of attractive, novel drug targets in the fields of: Oncology, Gynecology, Cardiology, Hematology and Ophtalmology.
Característiques principals
The grants fund research on novel drug targets as a basis for the development of new therapeutic approaches, as well as research on disease-related biomarkers in the therapeutic fields mentioned below, by combining expertise from industry and academia.

  • Oncology: Focus on tumor cell proliferation, survival signaling, transcription and chromatin modulation, cell cycle regulation, tumor metabolism, hypoxia, cancer immunotherapy and Antibody Drug Conjugates (ADC) as well as Targeted Thorium Conjugates (TTC).
  • Gynecology: Focus on novel treatment options for endometriosis (incl. adenomyosis uteri/endometriosis interna) and uterine fibroids (uterine leiomyoma).
  • Cardiology: Focus on novel approaches to the care of chronic and/or acute pulmonary hypertension & adjacent lung indications, atrial fibrillation, heart failure, acute coronary syndrome, ischemic stroke, peripheral arterial occlusive disease, acute lung injury/adult respiratory distress syndrome, cardiorenal syndrome and including kidney and lung diseases.
  • Hematology: Focus on novel, innovative targets for hemophilia, hemoglobinopathies, bone marrow cell mobilization and renewal.
  • Ophthalmology: Treatment options for dry AMD/Geographic Atrophy and Stargardt’s disease.

    Target must be a nucleic acid or a protein (e.g. an enzyme, a receptor) whose activity can be modified by a drug
    Target should have shown to be effective/ mechanistically involved in the disease by relevant in vitro or in vivo models.
    Target is disease-modifying and/or has a proven function in the pathophysiology of a disease.

    Types of grants:
  • Support Grants For druggable targets that are at a very early stage of discovery; fixed grant approval letter; IP rights remain with the applicant
  • Focus Grants: for more mature ideas, e.g. to address specific aspects of a target as a first step towards transferring it to the drug discovery process; fixed grant approval letter; IP rights remain with the applicant.
    Grant types do not need to be selected by the grant applicant.
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
    Marta López: mlopez4@imim.es Ext.: 1576
    Carol Barnwell: cbarnwell@imim.es Ext.: 1670
    Convocatòria (URL)

    http://www.grants4targets.com/scripts/pages/en/index.php
    Requisits
    Researchers from universities, other academic research institutes and start-up companies from all over the world are eligible.
    Dotació
    Two types of grants:
  • Support Grants: €5,000-€10,000
  • Focus Grants: €10,000-€125,000
    • Documentació
    Grant applications can only be submitted via the electronic submission platform. It is only necessary to provide an abstract describing your idea and target, its characteristics and a separate description of its therapeutic potential, and a CV and relevant publications. Please note that only non-confidential information should be provided.
    https://mc.manuscriptcentral.com/grants4targets

    Arxius

    Arxiu